HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $451,000 | -25.9% | 10,839 | -53.2% | 0.01% | -33.3% |
| Q3 2020 | $609,000 | +33.6% | 23,159 | -10.0% | 0.02% | +114.3% |
| Q4 2019 | $456,000 | +204.0% | 25,742 | +150.5% | 0.01% | +40.0% |
| Q4 2018 | $150,000 | -83.1% | 10,277 | -77.2% | 0.01% | -64.3% |
| Q1 2018 | $885,000 | +61.2% | 45,130 | +5.3% | 0.01% | +133.3% |
| Q2 2017 | $549,000 | +104.9% | 42,849 | +107.1% | 0.01% | +100.0% |
| Q1 2017 | $268,000 | +45.7% | 20,687 | +51.0% | 0.00% | -25.0% |
| Q3 2015 | $184,000 | +34.3% | 13,700 | -3.7% | 0.00% | -33.3% |
| Q4 2014 | $137,000 | – | 14,226 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |